Mathematical model suggests current CAR-macrophage dosage is efficient to low pre-infusion tumour burden but refractory to high tumour burden

Shilian Xu, Maoxuan Liu

Source record

Source: Crossref

Published: Jan 1, 2026

DOI: 10.1016/j.jtbi.2025.112263

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.